Abstract:Journal of Endovascular Therapy, Ahead of Print. Objectives:Type I and III endoleaks following endovascular aneurysm repair (EVAR) can lead to catastrophic events that require major re-interventions. We reviewed our experience with aortic endograft re-interventions for type I and III endoleaks and other serious failures among different devices.Methods:We retrospectively reviewed patients with a prior EVAR who underwent open conversion (OC) or major endovascular intervention (MEI) (re-lining, cuff/limb extension, parallel graft) for type I/III endoleaks at our institution from 2002 to 2019. Baseline characteristics, procedural details, re-interventions, and outcomes were collected.Results:A total of 229 patients (194 men) underwent re-interventions for type I and III endoleaks after EVAR (90 OC, 139 MEI) for devices implanted between 1997 and 2019. Average age at re-intervention was 78±8.5 years. A total of 135 (59%) were implanted at our institution, whereas 93 (41%) were referred. Median time to re-intervention was 4 years with 25% to 75% interquartile range (IQR) of 2.2–6.6 years. There was no significant difference in baseline demographics or type of re-interventions (OC/MEI) between device types. 42/229 (18%) presented with ruptured aneurysms, 20/229 (9%) were symptomatic, whereas the rest presented with asymptomatic radiographic findings. Type 1A endoleak was present in 146/229 (63.8%—72 with proximal migration), type IB in 46/229 (20.1%), type IIIA in 37/229 (16.6%), type IIIB in 15/229 (6.5%), and persistent aneurysm sac growth with no radiographic evidence of an endoleak in 6/229 (2.6%). Devices included most commercial products: AFX, Excluder, AneuRx, Ancure, Endurant, and Zenith. A smaller number of investigational devices accounted for the rest. Type 1A endoleak was the most common indication for re-intervention among all devices except for AFX and ancure devices, proximal migration was a frequent presentation with AneuRx. AFX devices more frequently presented with a type III and ancure devices more frequently presented with a type IB endoleak.Conclusions:Serious failure modes after EVAR differ between endografts and occur throughout the follow-up period. This is important to guide targeted interrogation of surveillance studies and follow-up schedules, even for discontinued devices, as well as comparisons between various series and estimation of EVAR failure rates.Clinical ImpactSurveillance after EVAR is critical for long term success of the repair, understanding of the differential modes of failure of every graft available is important in the longitudinal evaluation of these endografts. Equally important is the understanding of the modes of failure of legacy endografts that are no longer on the market but still being followed, in order to be able to tailor a surveillance regiemn and the evntual repair if needed.

CIRSE Standards of Practice on Management of Endoleaks Following Endovascular Aneurysm Repair

Treatment strategies for endoleak after endovascular repair of the abdominal aortic aneurysm: A single center retrospective study

Strategies for endoleak treatment after endovascular abdominal aortic aneurysm repair: A single center retrospective study

Nature and significance of endoleaks and endotension: Summary of opinions expressed at an international conference

Serious Failure Modes After EVAR Are Device Specific

Implications and Late Outcomes of Type II Endoleaks After Endovascular Aneurysm Repair

A Systematic Review of an Emerging Trend for Addressing Type II Endoleak Following Endovascular Aortic Aneurysm Repair

Postoperative complications of endovascular repair of abdominal aortic aneurysms in poor-risk patients

[Complications in Endovascular Repair of Abdominal Aortic Aneurysms: Treatment and Prevention].

[Analysis of Endoleak in Short Term after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysms].

An Expert-Based Review on the Relevance and Management of Type 2 Endoleaks Following Endovascular Repair of Ruptured Abdominal Aortic Aneurysms

Endograft Collapse after Standard Endovascular Aneurysm Repair Implantation: A Report of Two Cases

Impact of Isolated Type 2 Endoleak on Subsequent Cardiovascular Events and Mortality

Complications and reinterventions after EVAR: are they decreasing in incidence?

Long-Term Outcomes of Staged Iliofemoral Endoconduits Prior to Complex Endovascular Aortic Aneurysm Repair

The Association between Plasma Proinflammatory Cytokine Concentrations and Endoleak after Endovascular Aortic Aneurysm Repair

Endovascular repair for infra-renal aortic aneurysms with supra-renal fixation endoprosthesis: Results and outcomes

Midterm Outcomes With the Nellix Endograft Alone or With Chimneys

Late events and mid-term results after endovascular aneurysm repair

Routine Inferior Mesenteric Artery Embolisation is Unnecessary Before Endovascular Aneurysm Repair

Type 2 endoleak embolization and utilization of non-contrast-enhanced magnetic resonance angiography (NCE-MRA) as a non-invasive imaging follow-up method.